Related Experiment Videos
Thyrotropin binding and adenylate cyclase stimulation in thyroid neoplasms
Surgery
|August 1, 1981
Summary
Thyroid-stimulating hormone (TSH) receptors coupled to adenylate cyclase are present in thyroid tumors. These receptors show altered binding and activity in neoplastic tissue, impacting thyroid function.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Thyroid-stimulating hormone (TSH) regulates thyroid function through specific receptors.
- Understanding TSH receptor function in thyroid neoplasms is crucial for diagnosing and treating thyroid diseases.
Purpose of the Study:
- To investigate the presence and characteristics of TSH receptors coupled to adenylate cyclase in benign and malignant thyroid tumors.
- To identify potential abnormalities in the TSH receptor-adenylate cyclase system within neoplastic thyroid tissue.
Main Methods:
- In vitro experiments involving TSH binding assays and adenylate cyclase activity measurements.
- Incubation of 125I-bovine TSH with particulate fractions from normal thyroid tissue and thyroid tumors (adenomas and carcinomas).
Main Results:
- Two distinct TSH receptor sites were identified in thyroid tissue.
- Thyroid adenomas and carcinomas exhibited reduced TSH receptor affinity and capacity compared to normal thyroid tissue.
- Neoplastic thyroid tissue showed a significantly greater adenylate cyclase response to TSH stimulation.
- A positive correlation was observed between TSH binding and adenylate cyclase activation in tumors, indicating functional coupling.
Conclusions:
- TSH receptors coupled to adenylate cyclase are present in both benign and malignant thyroid tumors.
- Abnormalities in TSH receptor binding and adenylate cyclase activity exist in neoplastic thyroid tissue.
- The observed TSH receptor-adenylate cyclase interactions in tumors are biologically significant.